Jove
Visualize
Contact Us

Related Experiment Videos

Can we reduce mortality in sepsis?

May S Chehab1

  • 1Department of Pediatrics, Armed Forces Hospital, Riyadh, Kingdom of Saudi Arabia.

Saudi Medical Journal
|March 30, 2004
PubMed
Summary

New sepsis treatments, including lung-protective ventilation and tight glucose control, are improving survival rates. This review guides intensivists on integrating these interventions to further reduce sepsis mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to surviving sepsis guidelines among pediatric intensivists. A national survey.

Saudi medical journal·2017
Same author

Septic pulmonary embolism secondary to Staphylococcus aureus septic thrombophlebitis in a pediatric patient.

Saudi medical journal·2013
Same author

Overview of bronchiolitis.

Saudi medical journal·2005
Same author

Pediatric living-related liver transplantation in Saudi Arabia.

Saudi medical journal·2002
Same author

Living-related liver transplantation for Crigler-Najjar syndrome in Saudi Arabia.

Clinical transplantation·2002
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Sepsis remains a leading cause of mortality despite advances in diagnosis and treatment.
  • Recent therapeutic interventions have shown promise in reducing sepsis-related deaths.

Purpose of the Study:

  • To review five key interventions for sepsis management.
  • To provide guidance for intensivists on integrating these therapies into intensive care units.
  • To optimize patient selection and timing for interventions to reduce mortality.

Main Methods:

  • Review of randomized controlled trials on sepsis interventions.
  • Analysis of interventions including lung-protective ventilation, early goal-directed therapy, recombinant human activated protein C, moderate-dose steroids, and tight glycemic control.

Main Results:

  • Lung-protective ventilation for ARDS/ALI, early goal-directed therapy, recombinant human activated protein C, moderate-dose steroids, and tight glycemic control have demonstrated mortality reduction in sepsis.
  • These interventions are not mutually exclusive and can be integrated.

Conclusions:

  • Implementing evidence-based interventions can significantly decrease sepsis mortality.
  • Optimal patient selection and timing are crucial for maximizing the effectiveness of sepsis therapies.
  • Integrated application of these strategies in the ICU setting is recommended.

Related Experiment Videos